E/CN.7/2016/1

Provisional agenda and annotations

E/CN.7/2016/2 - E/CN.15/2016/2

Report of the Executive Director on the activities of the United Nations Office on Drugs and Crime

E/CN.7/2016/3- E/CN.15/2016/3

Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime

E/CN.7/2016/4

Report of the Secretariat on the world situation with regard to drug abuse

E/CN.7/2016/5

Report of the Secretariat on the world situation with regard to drug trafficking, problem focusing on illicit drug trafficking and related offences

E/CN.7/2016/6 

Report of the Executive Director on Action taken by Member States to implement the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem

E/CN.7/2016/7

Note by the Secretariat on promoting coordination and alignment of decisions between the Commission on Narcotic Drugs and the Programme Coordinating Board of the Joint United Nations Programme on HIV/AIDS

E/CN.7/2016/8

Report of ED on responding to the prevalence of HIV/AIDS and other blood-borne disease among drug users

E/CN.7/2016/9

Note by the Secretariat on the scope of control of substances proposed scheduling recommendation WHO

E/CN.7/2016/10

Report of the Secretariat on action taken by the subsidiary bodies of the Commission on Narcotic Drugs

E/CN.7/2016/11

Report by the Secretariat on Strengthening international cooperation in combating illicit opiates originating in Afghanistan through continuous and reinforced support to the Paris Pact initiative

E/CN.7/2016/12- E/CN.15/2016/12

Note transmitting the proposed strategic framework for the period 2018-19

E/CN.7/2016/13

Outcome of the international seminar/workshop on the implementation of the United Nations Guiding Principles on Alternative Development and the Second International Conference on Alternative Development

E/CN.7/2016/14

Report of the ED on Strengthening international cooperation in preventing and combating illicit financial flows linked to drug trafficking, from the anti-money-laundering perspective

E/CN.7/2016/CRP.1

Contribution by UNODC in implementing the 2030 Agenda for Sustainable Development, and a proposed role of the CND and CCPCJ in reviewing the progress of the SDGs

E/CN.7/2016/CRP.2

New psychoactive substances: overview of trends, challenges and legal approaches

E/2016/28-E/CN.7/2016/16

Commission on Narcotic Drugs, Report on the fifty-ninth session 

E/CN.7/2016/CRP.9

Statements of financial implications presented to the Commission on Narcotic Drugs before its consideration of draft resolutions at its fifty-ninth session

E/CN.7/2016/CRP.10

List of documents before the Commission at its fifty-ninth session

E/CN.7/2016/15

Note by the Secretariat on Special session of the General Assembly on the world drug problem to be held in 2016   (Organizational arrangements)

UNODC/ED/2016/1

Report of  the Executive Director on the Special session of the General Assembly on the world drug problem, to be held in 2016

E/CN.7/2016/CRP.3

Paper submitted jointly by Germany and UNODC entitled "Towards development-oriented drug policies: alternative development in the UNGASS 2016 process"

E/CN.7/2016/CRP.4

International Standards for the Treatment of Drug Use Disorders - Draft for Field Testing

E/CN.7/2016/CRP.5

Summary of the President of the General Assembly on the Informal Interactive Stakeholder Consultation in Support of the Preparatory Process for the United Nations General Assembly Special Session on the World Drug Problem (UNGASS), held at the United Nations Headquarters, New York, on 10 February 2016

E/CN.7/2016/CRP.6

Declaration of Santo Domingo, submitted by Mexico

E/CN.7/2016/CRP.7

Report by the Inter-Parliamentary Union:  The world drug problem: Taking stock and strengthening the global response, Annual Parliamentary Hearing, United Nations Headquarters, 8-9 February 2016

E/CN.7/2016/CRP.8

Letter from Mr. Mogens Lykketoft, President of the General Assembly: Special session of the General Assembly on the world drug problem, nominations for the roundtables according to General Assembly resolution 70/181 and Commision on Narcotic Drugs decision 58/16

E/CN.7/2016/NGO.1

Written statement submitted by IOGT International

E/CN.7/2016/NGO.2

Written statement submitted by EURAD

E/CN.7/2016/NGO.3

Written statement submitted by Turkish Green Crescent

A/71/6 (Prog.13)

Proposed strategic framework for the period 2018-2019

A/71/6 (Prog.13)/Corr.1

Proposed strategic framework for the period 2018-2019 (corrigendum)

E/CN.7/2015/CRP.8 -

E/CN.15/2015/CRP.8

Proposed strategic framework for the period 2018-19 for the United Nations Office on Drugs and Crime

WHO Technical Report Series 998

37th report of the WHO Expert Committee on Drug Dependence (Pre-layout version)